Literature DB >> 1329855

In vivo trapping of hydroxyl free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP+.

T Obata1, C C Chiueh.   

Abstract

Increased formation of hydroxyl free radicals (.OH) reflected by .OH adduct of salicylate in brain dialysate was demonstrated during the sustained (more than 2 hours) dopamine overflow elicited by 75 nmol of 1-methyl-4-phenyldihydropyridine (MPDP+) and 1-methyl-4-phenylpyridinium (MPP+) in the rat striatum. Owing to its weak dopamine releasing action, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) did not significantly increase the .OH formation. This data suggests that sustained elevation of dopamine in the extracellular fluid elicited by MPTP analogues can be auto-oxidized, which in turn leads (possibly by indirect mechanisms) to the formation of cytotoxic .OH free radicals near the nigrostriatal terminals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329855     DOI: 10.1007/bf01245361

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  31 in total

Review 1.  Hydroxylation of salicylate as an assay for hydroxyl radicals: a cautionary note.

Authors:  B Halliwell; H Kaur; M Ingelman-Sundberg
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

2.  Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement.

Authors:  M W Cleeter; J M Cooper; A H Schapira
Journal:  J Neurochem       Date:  1992-02       Impact factor: 5.372

3.  Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.

Authors:  P Riederer; E Sofic; W D Rausch; B Schmidt; G P Reynolds; K Jellinger; M B Youdim
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

4.  Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Authors:  D T Dexter; C J Carter; F R Wells; F Javoy-Agid; Y Agid; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

5.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitro.

Authors:  Z L Rossetti; A Sotgiu; D E Sharp; M Hadjiconstantinou; N H Neff
Journal:  Biochem Pharmacol       Date:  1988-12-01       Impact factor: 5.858

6.  Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Authors:  E C Hirsch; J P Brandel; P Galle; F Javoy-Agid; Y Agid
Journal:  J Neurochem       Date:  1991-02       Impact factor: 5.372

7.  Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease.

Authors:  D Ben-Shachar; P Riederer; M B Youdim
Journal:  J Neurochem       Date:  1991-11       Impact factor: 5.372

8.  MPP+-induced efflux of dopamine and lactate from rat striatum have similar time courses as shown by in vivo brain dialysis.

Authors:  H Rollema; W G Kuhr; G Kranenborg; J De Vries; C Van den Berg
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

9.  In vivo autoxidation of dopamine in guinea pig striatum increases with age.

Authors:  B Fornstedt; E Pileblad; A Carlsson
Journal:  J Neurochem       Date:  1990-08       Impact factor: 5.372

10.  Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.

Authors:  C Mytilineou; G Cohen
Journal:  J Neurochem       Date:  1985-12       Impact factor: 5.372

View more
  11 in total

1.  Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.

Authors:  J Lotharius; L L Dugan; K L O'Malley
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

Review 2.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

Review 3.  MPTP mouse models of Parkinson's disease: an update.

Authors:  Gloria E Meredith; David J Rademacher
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

4.  Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice.

Authors:  F Fumagalli; R R Gainetdinov; Y M Wang; K J Valenzano; G W Miller; M G Caron
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

5.  Striatal metabolism of hexanal, a lipid peroxidation product, in the rat.

Authors:  V Jaar; L Ste-Marie; J A Montgomery
Journal:  Metab Brain Dis       Date:  1999-06       Impact factor: 3.584

Review 6.  Proteomic approach to studying Parkinson's disease.

Authors:  Jing Zhang; David R Goodlett
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

Review 7.  Nitric oxide and MPP+-induced hydroxyl radical generation.

Authors:  T Obata
Journal:  J Neural Transm (Vienna)       Date:  2006-02-06       Impact factor: 3.575

8.  Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter.

Authors:  F Fumagalli; R R Gainetdinov; K J Valenzano; M G Caron
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

Review 9.  Environmental estrogen-like chemicals and hydroxyl radicals induced by MPTP in the striatum: a review.

Authors:  Toshia Obata
Journal:  Neurochem Res       Date:  2002-05       Impact factor: 3.996

Review 10.  The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain.

Authors:  W A García-Suástegui; L A Ramos-Chávez; M Rubio-Osornio; M Calvillo-Velasco; J A Atzin-Méndez; J Guevara; D Silva-Adaya
Journal:  Oxid Med Cell Longev       Date:  2017-01-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.